Literature DB >> 8994282

Molecular mechanisms of angiogenesis: experimental models define cellular trafficking of FGF-1.

K K Hicks1, J T Shin, S R Opalenik, J A Thompson.   

Abstract

Numerous studies have established that stimulation of cell growth by members of the fibroblast growth factor (FGF) family of polypeptides is dependent upon an extracellular pathway. Acidic FGF (FGF-1), however, lacks a classical signal sequence for secretion, thereby making it difficult to evaluate regulation of biological activity by this growth factor. Efforts in this laboratory have utilized molecular techniques of retrovirology and transgenic modeling to introduce cDNA sequences encoding either an intracellular or extracellular form of FGF-1 into primary diploid cells to examine trafficking and compartmentalization of FGF-1. Several lines of evidence obtained from these models provide a compelling argument that the stimulation of FGF-1-associated cellular transformation is restricted to an extracellular, receptor-mediated pathway, involving protein tyrosine phosphorylation and nuclear localization. In addition, an unconventional secretion pathway for intracellular FGF-1 has been identified that involves mechanisms associated with oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994282

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  2 in total

Review 1.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

2.  The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage.

Authors:  Chi Zhang; Linbo Zhang; Shali Chen; Biao Feng; Xuemian Lu; Yang Bai; Guang Liang; Yi Tan; Minglong Shao; Melissa Skibba; Litai Jin; Xiaokun Li; Subrata Chakrabarti; Lu Cai
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.